CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 27, 2012--
AVEO Oncology (NASDAQ: AVEO) today announced that Tuan Ha-Ngoc,
president and chief executive officer, is scheduled to present at the 31st
Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2013 at
11:00 a.m. (PT) in San Francisco.
A live webcast of AVEO’s presentation can be accessed by visiting the
investors section of the company’s website at investor.aveooncology.com.
A replay of the webcast will be archived on the AVEO website for two
weeks following the presentation.
AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed
to discovering, developing and commercializing targeted therapies to
impact patients’ lives. AVEO’s proprietary Human Response PlatformTM
provides the company unique insights into cancer biology and is being
leveraged in the discovery and clinical development of its cancer
therapeutics. For more information, please visit the company’s website
Source: AVEO Oncology